Electro-Optical Announces MelaFind Study Results
Electro-Optical Sciences has announced positive results in a clinical trial of the MelaFind System, a handheld imaging device that detects melanomas at an early stage.
Member Spotlight
Focal Drug Delivery Helps Deadly Brain Tumor, Study Shows
A method of delivering chemotherapy drugs into a deadly type of brain tumor extended the lives of patients in early clinical trials.
Clarient Launches New Breast Cancer Test
Clarient is launching a new breast cancer test that helps physicians assess the probability of a patient’s cancer returning.
Studies Back Gen-Probe’s Prostate Cancer Test
Eight studies presented this week at the American Urological Association Annual Meeting suggest that Gen-Probe’s investigational test for the prostate cancer gene PCA3 may address some of the major challenges faced by urologists when diagnosing the disease.
Microline PENTAX Acquires Starion Instruments
Two strong players in the surgical-instrument field have joined forces. Microline PENTAX, a leading manufacturer of reposable surgical instruments for laparoscopic procedures, has acquired California-based Starion Instruments, a developer of instruments to arrest bleeding during surgical procedures.
Isto Gets Go-Ahead for Clinical Study of NuQu
ISTO Technologies has received FDA approval to begin a Phase I clinical study for NuQu, an injectable formulation of juvenile cartilage cells designed to treat chronic back pain caused by degenerative disc disease.
Major Milestone for Sunshine Heart
Sunshine Heart, a global company that develops cardiac assist devices, has successfully completed the first two implants of the company’s C-Pulse heart assist system under a 20-person clinical trial approved by the U.S. Food and Drug Administration.
First Patient Successfully Treated With Algisyl-LVR Device
Symphony Medical, a developer of novel biopolymer technologies for cardiac disorders, has successfully used its flagship Algisyl-LVR technology to treat their first human patient.
[Video Profile] TearLab Corporation
Patients who dread traditional blood tests (and the accompanying needles) may one day have reason to rejoice. San Diego device company TearLab is developing a point-of-care diagnostic test that uses tears to identify disease-indicating protein biomarkers.
Two Studies Cast Doubt On Common Prostate Cancer Test
A common prostate-cancer screening test may be largely ineffective, according to two new studies. Scientists in the U.S. and Europe found that the PSA blood test saves few lives and leads to unnecessary treatments for large numbers of men.